Fabio
76b8ec33a7
Ingested titles 12–51 and 54 from OLRC USLM XML @119-100 (the whole Code now, uniform edition; Title 53 is reserved/empty). LegalText 11,221 -> 59,740; repo total 105,704 records. Deterministic (byte-identical rerun, verified on Title 42's 8,356 sections); make check green. make legal-us-code default now covers every title. Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
42 lines
2.6 KiB
Markdown
42 lines
2.6 KiB
Markdown
---
|
||
type: "LegalText"
|
||
title: "42 U.S.C. § 300gg–19b"
|
||
description: "Information on prescription drugs"
|
||
jurisdiction: "us"
|
||
corpus: "united_states_code"
|
||
kind: "code_section"
|
||
title_number: 42
|
||
title_name: "THE PUBLIC HEALTH AND WELFARE"
|
||
chapter_number: "6A"
|
||
chapter_name: "PUBLIC HEALTH SERVICE"
|
||
section: "300gg–19b"
|
||
citation: "42 U.S.C. § 300gg–19b"
|
||
status: "current"
|
||
release_point: "119-100"
|
||
release_date: "2026-06-26"
|
||
source: "official"
|
||
source_url: "https://uscode.house.gov/download/releasepoints/us/pl/119/100/xml_usc42@119-100.zip"
|
||
source_identifier: "/us/usc/t42/s300gg–19b"
|
||
source_file: "data/legal/raw/us/code/title-42/usc42.xml"
|
||
source_hash: "899acf5eb5a4a8a4d32651b7a5b8ec275e88cbabd0982d213005e19657fb7b3e"
|
||
raw_snapshot_hash: "644321055a08eb1f260a6a3e31ac157fa024756abf612a9fd6857e7e400cf24e"
|
||
text_hash: "dc6c827eacffb37b66a165e0cfa06abd6d88ca0969d39813ffbed1381fd4b4e0"
|
||
retrieved_at: "2026-07-04"
|
||
confidence: "official"
|
||
tags: ["legal", "us-code"]
|
||
---
|
||
|
||
# 42 U.S.C. § 300gg–19b - Information on prescription drugs
|
||
|
||
## Text
|
||
|
||
(a) In general A group health plan or a health insurance issuer offering group or individual health insurance coverage shall—
|
||
|
||
(1) not restrict, directly or indirectly, any pharmacy that dispenses a prescription drug to an enrollee in the plan or coverage from informing (or penalize such pharmacy for informing) an enrollee of any differential between the enrollee’s out-of-pocket cost under the plan or coverage with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using any health plan or health insurance coverage; and
|
||
|
||
(2) ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan or health insurance coverage does not, with respect to such plan or coverage, restrict, directly or indirectly, a pharmacy that dispenses a prescription drug from informing (or penalize such pharmacy for informing) an enrollee of any differential between the enrollee’s out-of-pocket cost under the plan or coverage with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using any health plan or health insurance coverage.
|
||
|
||
(b) Definition For purposes of this section, the term “out-of-pocket cost”, with respect to acquisition of a drug, means the amount to be paid by the enrollee under the plan or coverage, including any cost-sharing (including any deductible, copayment, or coinsurance) and, as determined by the Secretary, any other expenditure.
|
||
|
||
(July 1, 1944, ch. 373, title XXVII, § 2729, as added Pub. L. 115–263, § 2, Oct. 10, 2018, 132 Stat. 3672.)
|